Christian Casal, PhD
Serial VC & PE investor with multiple successful exits
Formerly CEO of McKinsey Switzerland, and member of McKinsey’s Global Board, mostly focusing on financial services (Head of EMEA Banking)
Various Board positions in Switzerland incl. Lucernefestival, and Tafeln Schweiz
PhD and M.Sc. in Business Administration from University of St. Gallen
Stephen Oesterle, MD
Venture Partner at New Enterprise Associates in Palo Alto since 2015; serving on several Boards (e.g., Baxter)
Formerly Medtronic’s Senior Vice-President for Medicine and Technology and a member of the Medtronic Executive Committee for 14 years
Served on the faculty at Stanford and Harvard Medical Schools while directing the Invasive Cardiology Services at Stanford Hospital and the Massachusetts General Hospital
Young Sohn, MS
Former Corporate President and Chief Strategy Officer of Samsung Electronics
Chairman of the Board of Harman International, served on the Boards of Arm, Cadence and Cymer
Seed investor to companies such as Berkeley Lights, Fungible, Zoom Video, Graphcore and TTTech, continuous to be very active venture investor
Jessie Inchauspé
aka Glucose Goddess
Author of the international bestseller “Glucose Revolution” (2022) and “The Glucose Goddess Method” (2023)
Founder of Glucose Goddess, providing actionable advice based on cutting-edge science, focusing on the importance of balancing one’s blood sugar to maximize health and longevity, which has garnered a community of >2m followers
Formerly Senior Product Manager at 23andMe, focusing on bridging genetic information and consumer behavior change
Edward J. Ludwig, MBA
Board member of Boston Scientific and Board member at CVS health
Former Chairman of the Board of Becton, Dickinson and Company from 2002-2012, and its CEO from 2000-2011
Formerly served as a Director of Xylem, and as Vice Chair of the Board of trustees of the Hackensack University Medical Center Network
Jürgen Popp, Prof.
Chair of Physical Chemistry at Friedrich Schiller University Jena
Scientific Director of the Liebniz Institute of Photonic Technology, Jena
Research interest includes biophotonics, in particular with the development and application of innovative Raman techniques for biomedical diagnosis
PhD in Chemistry from University of Würzburg, Post-doc from Yale University
Mervyn Singer, Prof. MD
Professor of Intensive Care Medicine at University College London with over 30 years’ research experience
Has developed and co-developed medical devices resulting in e.g., reduced length of stay after surgery, improved COVID-19 care
Co-chaired the Sepsis-3 International Task Force that redefined sepsis (Singer JAMA 2016); paper has had >3 million views and is one of the most heavily cited in the scientific literature over the past 5 years
Petra Jantzer, PhD
Managing Director with Accenture focused on technology and digitization
VP of the Board of Advance – women in business society
Formerly Partner with McKinsey, where she worked for 17 years, focused on Pharma, Biotech & Technology
Post-doc, PhD and MSc in Biology and Immunology at Ludwig-Maximilians University
Lutz Heinemann, Prof.
3 years as Assistant Professor in Neurophysiology at Düsseldorf University and 14 years at the Clinic for Nutrition and Metabolism
Founder and CEO of the Profil Institut für Stoffwechselforschung in Neuss, Germany until 2009; member of multiple diabetes associations, Scientific Advisory Boards for pharmaceutical companies, and Managing Editor of the Journal of Diabetes Science and Technology
Research focuses on insulin pharmacology and diabetes technology; coordinated EU-funded project AP@home from 2010 to 2015
Omer Dzemali, Prof. MD
Chief Physician of the Clinic for Cardiac Surgery in the City Hospital Triemli Zurich
More than 20 years’ of experience in cardiology
Full Professor in the Faculty of Medicine, State University Tetova (Macedonia); Lecturer in Goethe-Universität Frankfurt am Main and University of Zurich
Doctorate in Medicine from Johannes Gutenberg-Universität in Mainz
Lui Forni, Prof. MD
Professor of Intensive Care Medicine at University of Surrey and Royal Surrey Hospital NHS Foundation Trust
Wide ranging research experience ranging from basic physical chemistry through to patient centred clinical trials
Research interests focus on extracorporeal techniques and novel biomarkers for acute kidney injury translating research from the bench to the bedside. Published extensively particularly in critical care nephrology
Roland Betz, Dipl-Ing
45 years’ experience with medical devices (e.g., patient monitoring, dental, digital imaging, linear accelerators, dialysis, reha, etc.)
Roles included VP of Quality and Regulatory Affairs with Siemens, Gambro/Baxter and Invacare
International involvement and contacts with regulatory authorities in the EU, USA, China and India
Founder of an independent consulting company (RBQ!)
Andrew Berger, Prof.
Professor of Optics and of Biomedical Engineering, University of Rochester (USA)
Research interest in biomedical optics, particularly noninvasive spectroscopic assessment of biological tissues and single cells
PhD in Physics from MIT, post-doc at Beckman Laser Institute and Medical Clinic, University of California/Irvine
Oern Stuge, MD, MBA
Physician executive with 30+ years of international experience in life sciences
Currently Chairman of Orsco Lifesciences, successfully selling/listing 9 companies, including a unicorn
Former Medtronic’s Senior Vice-President and President of EMEA, Canada & emerging markets for 12 years, founded the Structural Heart Division and launched the first commercially available percutaneous heart valve in the world
Jeffrey Brewer
Current CEO of Q Bio (San Carlos, CA)
Formerly CEO and co-founder of Bigfoot Biomedical, acquired by Abbott in 2023
Served as CEO & president of JDRF (formerly Juvenile Diabetes Research Foundation) from 2010 to 2014
Initiated the JDRF Artificial Pancreas Project while serving as a Board member, donor, and volunteer
Andy Weymann, MD, MBA
Executive, Board member, advisor and investor with extensive experience in business development, medical affairs, medical education, clinical affairs and patient-safety
Adept in navigating interactions with global regulatory authorities and achieving business growth through decisive leadership
Ex-CMO at Smith& Nephew, former managing Director at AO Education, and active as Board member, advisor and in other leadership roles; MD from University of Zürich